Legal & General Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98M | Sell |
2,719,093
-91,787
| -3% | -$3.31M | 0.02% | 519 |
|
|
2025
Q1 | $87.5M | Buy |
2,810,880
+176,998
| +7% | +$5.51M | 0.02% | 531 |
|
|
2024
Q4 | $67.2M | Buy |
2,633,882
+46,030
| +2% | +$1.17M | 0.02% | 571 |
|
|
2024
Q3 | $73.2M | Buy |
2,587,852
+27,423
| +1% | +$776K | 0.02% | 573 |
|
|
2024
Q2 | $67.5M | Buy |
2,560,429
+191,625
| +8% | +$5.05M | 0.02% | 570 |
|
|
2024
Q1 | $71.9M | Sell |
2,368,804
-5,247
| -0.2% | -$159K | 0.02% | 550 |
|
|
2023
Q4 | $66.7M | Sell |
2,374,051
-172,587
| -7% | -$4.85M | 0.02% | 562 |
|
|
2023
Q3 | $69.1M | Buy |
2,546,638
+132,008
| +5% | +$3.58M | 0.02% | 546 |
|
|
2023
Q2 | $74.2M | Buy |
2,414,630
+161,230
| +7% | +$4.96M | 0.02% | 549 |
|
|
2023
Q1 | $81.2M | Buy |
2,253,400
+14,464
| +0.6% | +$521K | 0.03% | 523 |
|
|
2022
Q4 | $88.5M | Sell |
2,238,936
-38,661
| -2% | -$1.53M | 0.03% | 488 |
|
|
2022
Q3 | $91.5M | Buy |
2,277,597
+44,302
| +2% | +$1.78M | 0.04% | 476 |
|
|
2022
Q2 | $93.9M | Buy |
2,233,295
+108,455
| +5% | +$4.56M | 0.03% | 499 |
|
|
2022
Q1 | $82.8M | Buy |
2,124,840
+282,324
| +15% | +$11M | 0.03% | 579 |
|
|
2021
Q4 | $73.4M | Buy |
1,842,516
+347,486
| +23% | +$13.8M | 0.02% | 604 |
|
|
2021
Q3 | $54M | Buy |
1,495,030
+23,793
| +2% | +$860K | 0.02% | 662 |
|
|
2021
Q2 | $60.3M | Buy |
1,471,237
+68,665
| +5% | +$2.81M | 0.02% | 652 |
|
|
2021
Q1 | $61.2M | Buy |
1,402,572
+928,993
| +196% | +$40.5M | 0.02% | 622 |
|
|
2020
Q4 | $23.7M | Buy |
473,579
+447,246
| +1,698% | +$22.4M | 0.01% | 802 |
|
|
2020
Q3 | $1.11M | Sell |
26,333
-40,019
| -60% | -$1.68M | ﹤0.01% | 1993 |
|
|
2020
Q2 | $3.22M | Buy |
+66,352
| New | +$3.22M | ﹤0.01% | 1517 |
|